Skip to content

Developing a pictorial chart to track symptoms and progress of illness in person with schizophrenia

Developing and Validating a pictorial chart to track the longitudinal curse of Schizophrenia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098663
Enrollment
30
Registered
2025-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Rhea Varshney
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of schizophrenia Consenting to take part in study

Exclusion criteria

Exclusion criteria: Participants will be excluded if they have a history or current diagnosis of any of the following: 1. Chronic Neurodegenerative or neurological disorders leading to sequelae and/or causing behavioural or cognitive deficits, e.g., Alzheimer s disease, Parkinson s disease, Dementia, epilepsy or seizure disorders, multiple sclerosis, hepatic encephalopathy. 2. History of stroke or cerebrovascular accidents 3. Traumatic brain injury (TBI) with loss of consciousness or lasting cognitive effects 4. Uncontrolled medical conditions like diabetes mellitus 5. Substance use disorders (current or past) or dependance except Nicotine dependence syndrome.

Design outcomes

Primary

MeasureTime frame
Development and validation of a pictorial chart to track the longitudinal course of schizophreniaTimepoint: Cross sectional study

Secondary

MeasureTime frame
To assess the clinical features of Schizophrenia under all 6 domains; Positive symptoms, Negative symptoms, cognitive deficits, psychomotor symptoms, manic mood symptoms, depressive mood symptoms. To ascertain the clinical findings through appropriate rating scales in those domains and to compare the severity with ICD-11 guidelines. To chart longitudinal course of the illness based on information obtained from records and interview with follow up at 3 months.Timepoint: Cross sectional study

Countries

India

Contacts

Public ContactDr Rajeshkrishna Bhandary P

Kasturba Medical College, Manipal

rajesh.kbp@manipal.edu9844542567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026